As hormone-mimicking therapies, GLP-1 and GLP-1/GIP act on natural pathways that help regulate appetite, insulin signaling, and inflammation
Studies suggest that lowering NNMT levels may help counteract some of the mechanisms underlying impaired stem cell function in these disorders
Metabolic approaches: GLP-1 Incretins (semaglutide): appetite suppression | GLP-1/GIP incretins (tirzepatide): dual hormonal agonism | 5-Amino-1MQ: NNMT enzyme inhibition a non-hormonal mechanism, directly targeting lipid and NAD+ metabolism
European Journal of Cancer Prevention , 33 (3), 208216
Monitoring Progress: Initial testing allows us to track your improvement over time, adjusting dosages to ensure you achieve sustained energy, optimal wellness, and mental clarity safely and effectively